These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 20359144

  • 1. New therapeutic strategies for renal cell carcinoma.
    Wood LS.
    Urol Nurs; 2010; 30(1):40-53. PubMed ID: 20359144
    [Abstract] [Full Text] [Related]

  • 2. [Novelties in the treatment for advanced renal-cell cancer].
    Maráz A.
    Orv Hetil; 2011 Apr 24; 152(17):655-62. PubMed ID: 21464023
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sunitinib, sorafenib and mTOR inhibitors in renal cancer.
    Radulovic S, Bjelogrlic SK.
    J BUON; 2007 Sep 24; 12 Suppl 1():S151-62. PubMed ID: 17935273
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Targeted therapy for metastatic renal cell carcinoma.
    Motzer RJ, Bukowski RM.
    J Clin Oncol; 2006 Dec 10; 24(35):5601-8. PubMed ID: 17158546
    [Abstract] [Full Text] [Related]

  • 7. [Renal cell carcinoma management and therapies in 2010].
    Albouy B, Gross Goupil M, Escudier B, Massard C.
    Bull Cancer; 2010 Dec 10; 97():17-28. PubMed ID: 20418201
    [Abstract] [Full Text] [Related]

  • 8. Targeted therapies in metastatic renal cancer in 2009.
    Bastien L, Culine S, Paule B, Ledbai S, Patard JJ, de la Taille A.
    BJU Int; 2009 May 10; 103(10):1334-42. PubMed ID: 19338565
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Major treatment improvements encourage kidney cancer researchers to seek further gains.
    Tuma RS.
    J Natl Cancer Inst; 2008 Sep 03; 100(17):1202-3. PubMed ID: 18728277
    [No Abstract] [Full Text] [Related]

  • 13. Novel kinase inhibitors in renal cell carcinoma: progressive development of static agents.
    Desai AA, Stadler WM.
    Curr Oncol Rep; 2005 Mar 03; 7(2):116-22. PubMed ID: 15717945
    [Abstract] [Full Text] [Related]

  • 14. New treatment approaches in metastatic renal cell carcinoma.
    Mancuso A, Sternberg CN.
    Curr Opin Urol; 2006 Sep 03; 16(5):337-41. PubMed ID: 16905978
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Targeted therapies: sequential and combined treatments].
    Gross-Goupil M, Escudier B.
    Bull Cancer; 2010 Sep 03; 97():65-71. PubMed ID: 20418205
    [Abstract] [Full Text] [Related]

  • 17. Targeted therapies for the treatment of metastatic renal cell carcinoma: clinical evidence.
    Hutson TE.
    Oncologist; 2011 Sep 03; 16 Suppl 2(Suppl 2):14-22. PubMed ID: 21346036
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.